Wichmann patent opposition analysis

The comprehensive analysis of Wichmann opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Wichmann

Patent NumberTitleApplicantOpposition DateOpposition Company
Assay For Jc Virus AntibodiesBIOGEN MAAug 19, 2025POLPHARMA BIOLOGICS
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 6, 2025WUESTHOFF & WUESTHOFF
Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 5, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 10, 2025WUESTHOFF & WUESTHOFF
Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTISJan 15, 2025POLPHARMA
Guide Rna With Chemical ModificationsAGILENTJan 14, 2025WUESTHOFF & WUESTHOFF
Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024WUESTHOFF & WUESTHOFF
Methods And Compositions For The Targeted Modification Of A GenomeREGENERON PHARMACEUTICALSDec 12, 2024WUESTHOFF & WUESTHOFF
Methods For Treating Eye DisordersACCELERON PHARMASep 18, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB
Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VegfREGENERON PHARMACEUTICALSApr 24, 2024WUESTHOFF & WUESTHOFF